Hyperbaric Oxygen Therapy (HBOT) is reimbursable by Medicare, Kaiser Permanente, and insurance companies for the following indications:
- Chronic refractory osteomyelitis, unresponsive to conventional medical and surgical management
- Osteoradionecrosis as an adjunct to conventional treatment
- Soft tissue radionecrosis as an adjunct to
- Diabetic wounds of the lower extremities if these 3 criteria are met:
- Patient has Type 1 or Type 2 diabetes and has a lower extremity wound that is due to diabetes.
- Patient has a wound classified as Wagner grade III or higher.
An adequate course of standard wound therapy has failed.
- Preparation and preservation of compromised skin grafts
- Crush injuries and suturing of severed limbs
- Acute peripheral arterial insufficiency
- Acute traumatic peripheral ischemia
- Actinomycosis, as an adjunct to conventional therapy when the disease process is refractory to antibiotics and surgical treatment